In vivo (Athens, Greece)
Cure8 research brief
Why This Matters
The study explores how gut inflammation might influence liver autoimmune disease, which is relevant because people with IBD can have associated autoimmune cholangitis conditions. Understanding immune and metabolic links could point to multi-organ treatment strategies in the future.
Who Should Pay Attention
Researchers studying gut–liver immune interactions, clinicians managing patients with IBD and coexisting autoimmune cholangitis (PBC/PSC), and translational scientists interested in immune-pathway and metabolite-mediated regulation.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The research used a transgenic mouse model of primary biliary cholangitis (PBC) and chemically induced acute colitis (dextran sodium sulfate).
Researchers measured colon and liver pathology, immune cell populations by flow cytometry and immunostaining, inflammatory gene expression by qRT-PCR, and untargeted metabolomics to look for metabolites linked to immune regulation.
Key findings reported in the abstract: acute colitis worsened colonic injury but was associated with reduced hepatic inflammation, fewer liver-infiltrating lymphocytes (especially CD8+ T-cells), and a macrophage shift from M1 to M2 without a change in total macrophage numbers. Several metabolites potentially linked to immune modulation were identified.
Keep In Mind
This classification and brief are grounded in the article abstract and full-text extraction from Europe PMC; findings are from a mouse model and are exploratory. The abstract-level summary does not replace reading the full paper for methodological detail.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationIn vivo (Athens, Greece)
AuthorsHe M, Liu H, Zhang M +4 more
Study typeJournal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedSep 1, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Molecular regulatory mechanism of TRPV4-mediated calcium-dependent 5-HT secretion from enterochromaffin cells and its involvement in ulcerative colitis
The study links a cellular signaling pathway that increases serotonin release from gut enterochromaffin cells to inflammation in a mouse model of ulcerative colitis. If confirmed, blocking TRPV4 could become a research...
Fusobacterium nucleatum- derived succinic acid aggravates colitis by triggering macrophage pro-inflammatory phenotypic transformation via SUCNR1/NF-κB axis.
If true, a common gut microbe (Fusobacterium nucleatum) and its metabolite succinic acid could worsen intestinal inflammation by changing macrophage behavior, suggesting new targets to reduce flares or mucosal injury in...
Researchers find mechanisms that may lead to IBD
The findings point to an immune-cell change that may happen before Crohn’s symptoms appear, which could help predict relapse or guide future therapies. That could eventually affect monitoring or new treatment strategies...